Pama Pharmaceutical IVS: Financial statements 2017
CVR: 37228087
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Pama Pharmaceutical IVS (CVR 37228087) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2017 report amounted to DKK 3,000. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 3,000
- Total Assets
- DKK 3,000
Official annual report
Keep an eye on Pama Pharmaceutical IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 14, 2017, Martin Jensen has stepped down as director of Pama Pharmaceutical IVS.
As of December 14, 2017, Jingjing Gao has stepped down as director of Pama Pharmaceutical IVS.
Pama Pharmaceutical IVS has published its interim report for the period November 13, 2015 – December 31, 2016.
About Pama Pharmaceutical IVS
Pama Pharmaceutical IVS was a Danish company of the type Iværksætterselskab based in Virum, founded in 2015. The company has been dissolved on 4 July 2018. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2017, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2017 report amounted to DKK 3,000.